Senetas Corporation Ltd (SEN)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 2.300 |
|---|---|
| 52-week range | 1.615 – 3.400 |
| Return, 1 month / 3 months | −9.8% / −24.2% |
| Return, 1 year / 3 years | −11.6% / +24.2% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 59.4% |
| Worst drawdown (1 year) | -35.7% |
| Average daily value traded | 0.04M AUD |
| Dividend yield | 9.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Senetas Corporation is an Australian technology company that develops hardware-based network encryption products for organisations that need to protect data travelling between sites. Its encryptors, marketed under the Certes name, are used by government agencies, defence bodies, financial institutions and other enterprises to secure wide area network links. The company is based in Australia and works with partners to distribute its encryption equipment to customers around the world.
Senetas Corporation Ltd trades under the code SEN on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Senetas Corporation Ltd (SEN) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.300 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 611 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.6% and over the last three months it fell 24.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -5.1% | ||
| From 52-week high | -30.4% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -24.2% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | -2.0% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 59.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.7% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.04M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 9.2% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.9% |
|---|---|
| 1 month | −9.8% |
| 3 months | −24.2% |
| 6 months | +15.0% |
| 1 year | −11.6% |
| 3 years | +24.2% |
| 5 years | −42.1% |
Signals
| 50-day / 200-day average | 2.673 / 2.424 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.109 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jul 2026 | AUD 0.2111 |
| 19 Nov 2025 | AUD 0.0012 |
| 28 Nov 2019 | AUD 0.0005 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.